A modelled cost-effectiveness analysis of switching patients with poorly controlled type 2 diabetes to insulin detemir from oral antidiabetics or NPH in the Austrian setting; Data from the predictive study

Lars Stechemesser, Raimund Weitgasser, M Hofmann, M Aagren, R Mihaljevic

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageEnglish
Pages (from-to)A227-A227
JournalVALUE IN HEALTH
Volume11
Issue number3
DOIs
Publication statusPublished - 2008

Cite this